The invention relates to five membered heterocyclic ring bridged ring derivatives, a preparation method thereof and its application in medicine. Specifically, the present invention relates to a new five-membered heteroaromatic bi-bridged ring derivative shown in general formula (I), its preparation method, pharmaceutical compositions containing the derivative and its use as a therapeutic agent, in particular as a TGF_beta inhibitor, and in preparation for treatment, prevention or reduction of cancer mediated by excessive expression of TGF_beta. The use of drugs in which the substituents of general formula (I) are the same as those in specifications.
【技术实现步骤摘要】
【国外来华专利技术】PCT国内申请,说明书已公开。
【技术保护点】
PCT国内申请,权利要求书已公开。
【技术特征摘要】
【国外来华专利技术】2016.10....
【专利技术属性】
技术研发人员:余尚海,杨方龙,严晶晶,吴晓,贺峰,陶维康,
申请(专利权)人:江苏恒瑞医药股份有限公司,上海恒瑞医药有限公司,
类型:发明
国别省市:江苏,32
还没有人留言评论。发表了对其他浏览者有用的留言会获得科技券。